Market closedNon-fractional
Oramed Pharmaceuticals/ORMP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Oramed Pharmaceuticals
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Ticker
ORMP
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
New York, United States
Employees
-
Website
www.oramed.com
ORMP Metrics
BasicAdvanced
$103M
Market cap
9.86
P/E ratio
$0.26
EPS
1.86
Beta
-
Dividend rate
Price and volume
Market cap
$103M
Beta
1.86
Financial strength
Current ratio
5.278
Quick ratio
5.263
Long term debt to equity
0.164
Total debt to equity
19.647
Interest coverage (TTM)
-5.14%
Management effectiveness
Return on assets (TTM)
-4.65%
Return on equity (TTM)
6.48%
Valuation
Price to earnings (TTM)
9.863
Price to revenue (TTM)
152.681
Price to book
0.61
Price to tangible book (TTM)
0.61
Price to free cash flow (TTM)
-16.389
Growth
Revenue change (TTM)
-75.06%
Earnings per share change (TTM)
-134.31%
What the Analysts think about ORMP
Analyst Ratings
Majority rating from 2 analysts.
ORMP Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
$1.5M
-88.72%
Profit margin
0.00%
NaN%
ORMP Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.03
-$0.08
$0.33
$0.04
-
Expected
-$0.10
-$0.09
-$0.12
$0.02
-$0.02
Surprise
-70.00%
-5.88%
-375.00%
100.00%
-
ORMP News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Oramed Pharmaceuticals stock?
Oramed Pharmaceuticals (ORMP) has a market cap of $103M as of July 27, 2024.
What is the P/E ratio for Oramed Pharmaceuticals stock?
The price to earnings (P/E) ratio for Oramed Pharmaceuticals (ORMP) stock is 9.86 as of July 27, 2024.
Does Oramed Pharmaceuticals stock pay dividends?
No, Oramed Pharmaceuticals (ORMP) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Oramed Pharmaceuticals dividend payment date?
Oramed Pharmaceuticals (ORMP) stock does not pay dividends to its shareholders.
What is the beta indicator for Oramed Pharmaceuticals?
Oramed Pharmaceuticals (ORMP) has a beta rating of 1.86. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Oramed Pharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.